Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-06-092577
Filing Date
2006-04-28
Accepted
2006-04-28 13:52:02
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO THE ANNUAL REPORT FOR AKESIS PHARMACEUTICALS d10ka.htm 10-K/A 755872
2 CONSENT OF SWENSON ADVISORS, LLP dex231.htm EX-23.1 1828
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 10344
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 10320
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 4887
6 GRAPHIC g93001g76b52.jpg GRAPHIC 70034
  Complete submission text file 0001193125-06-092577.txt   881425
Mailing Address 888 PROSPECT STREET SUITE 320 LA JOLLA CA 92037
Business Address 888 PROSPECT STREET SUITE 320 LA JOLLA CA 92037 8586460789
AKESIS PHARMACEUTICALS, INC. (Filer) CIK: 0001042420 (see all company filings)

EIN.: 841409219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-27409 | Film No.: 06788749
SIC: 7389 Services-Business Services, NEC